Genocea Reports Fourth Quarter and Full-Year 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Genocea Biosciences (GNCA) PT Lowered to $2 at Cowen
February 15, 2018 3:00 PM ESTCowen lowered its price target on Genocea Biosciences (NASDAQ: GNCA) to $2.00 (from $5.00) while maintaining a Outperform rating.
Analyst Phil Nadeau commented, "Genocea reported Q4 financials including a net loss of $11MM and a pro-forma cash balance of $64MM. Meanwhile, lead... More
